{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:27:57Z","timestamp":1791581277926,"version":"4.3.4"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.574669","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:43:45Z","timestamp":1602045825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Benedetta","family":"Bonardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Massarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bruzzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oranite","family":"Goldrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Mangili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Anserini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Spinaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Arecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ceppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Demeestere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American society of clinical oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/humupd\/dmn063","article-title":"The current knowledge on radiosensitivity of ovarian follicle development stages","volume":"15","author":"Adriaens","year":"2009","journal-title":"Hum Reprod Update."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0545-7","article-title":"Cancer and fertility preservation: international recommendations from an expert meeting","volume":"14","author":"Lambertini","year":"2016","journal-title":"BMC Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum Reprod Update."},{"key":"B6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fonc.2019.00575","article-title":"Impact of taxanes, endocrine therapy, and deleterious germline BRCA mutations on anti-m\u00fcllerian hormone levels in early breast cancer patients treated with anthracycline- and cyclophosphamide-based chemotherapy","volume":"9","author":"Lambertini","year":"2019","journal-title":"Front Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.critrevonc.2019.03.010","article-title":"EUropean REcommendations for female FERtility preservation (EU-REFER): a joint collaboration between oncologists and fertility specialists","volume":"138","author":"Dolmans","year":"2019","journal-title":"Crit Rev Oncol Hematol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1178223420954179","DOI":"10.1177\/1178223420954179","article-title":"Burning questions in the oncofertility counseling of young breast cancer patients","volume":"14","author":"Arecco","year":"2020","journal-title":"Breast Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1002\/cncr.26649","article-title":"Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer","volume":"118","author":"Letourneau","year":"2012","journal-title":"Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.breast.2018.06.012","article-title":"Prospective study to optimize care and improve knowledge on ovarian function and\/or fertility preservation in young breast cancer patients: results of the pilot phase of the PREgnancy and Fertility (PREFER) study","volume":"41","author":"Lambertini","year":"2018","journal-title":"Breast."},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.breast.2019.07.001","article-title":"Fertility concerns, preservation strategies and quality of life in young women with breast cancer: baseline results from an ongoing prospective cohort study in selected European Centers","volume":"47","author":"Ruggeri","year":"2019","journal-title":"Breast."},{"key":"B12","unstructured":"electronic address: ASRM@asrm.org fertility preservation and reproduction in patients facing gonadotoxic therapies: an ethics committee opinion380610.1016\/j.fertnstert.2018.05.03430098684Fertil Steril1102018"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","author":"Lambertini","year":"2020","journal-title":"Ann Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2016.10.034","article-title":"Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: a GRADE approach for evidence evaluation and recommendations by the Italian association of medical oncology","volume":"71","author":"Lambertini","year":"2017","journal-title":"Eur J Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline Update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod."},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/23809000.2017.1270760","article-title":"Methods of controlled ovarian stimulation for embryo\/oocyte cryopreservation in breast cancer patients","volume":"2","author":"Lambertini","year":"2017","journal-title":"Expert Rev Quality Life Cancer Care."},{"key":"B18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.breast.2018.08.099","article-title":"The BCY3\/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients","volume":"42","author":"Lambertini","year":"2018","journal-title":"Breast."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil Steril."},{"key":"B21","doi-asserted-by":"publisher","first-page":"j138","DOI":"10.1136\/bmj.j138","article-title":"Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis","volume":"356","author":"Wang","year":"2017","journal-title":"BMJ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"CD010287","DOI":"10.1002\/14651858.CD010287.pub3","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"5","author":"Franik","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.rbmo.2009.06.008","article-title":"Aromatase inhibitors for female infertility: a systematic review of the literature","volume":"19","author":"Polyzos","year":"2009","journal-title":"Reprod Biomed Online."},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12958-017-0288-8","article-title":"Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?","volume":"15","author":"Haas","year":"2017","journal-title":"Reprod Biol Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.fertnstert.2017.08.017","article-title":"In vitro fertilization treatments with the use of clomiphene citrate or letrozole","volume":"108","author":"Haas","year":"2017","journal-title":"Fertil Steril."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e108219","DOI":"10.1371\/journal.pone.0108219","article-title":"Congenital malformations among babies born following letrozole or clomiphene for infertility treatment","volume":"9","author":"Sharma","year":"2014","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","article-title":"Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study","volume":"26","author":"Azim","year":"2008","journal-title":"J Clin Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejogrb.2017.09.023","article-title":"Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: a single center retrospective cohort study","volume":"218","author":"Arya","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"CD008528","DOI":"10.1002\/14651858.CD008528.pub3","article-title":"Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation","volume":"11","author":"Kamath","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/jhrs.JHRS_120_16","article-title":"A study of controlled ovarian stimulation with clomiphene citrate or letrozole in combination with gonadotropins and IUI in unexplained infertility","volume":"10","author":"Hembram","year":"2017","journal-title":"J Hum Reprod Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/09513590.2016.1177013","article-title":"Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes\u2020","volume":"32","author":"Pereira","year":"2016","journal-title":"Gynecol Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12958-018-0443-x","article-title":"Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients vs. conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers","volume":"17","author":"Goldrat","year":"2019","journal-title":"Reprod Biol Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/09513590.2013.819083","article-title":"Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?","volume":"29","author":"Revelli","year":"2013","journal-title":"Gynecol Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/humrep\/dew355","article-title":"Response to ovarian stimulation is not impacted by a breast cancer diagnosis","volume":"32","author":"Quinn","year":"2017","journal-title":"Hum Reprod."},{"key":"B37","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.eurox.2019.100049","article-title":"Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients","volume":"4","author":"Sonigo","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/humrep\/dev155","article-title":"Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients","volume":"30","author":"Goldrat","year":"2015","journal-title":"Hum Reprod."},{"key":"B39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/GCO.0000000000000180","article-title":"Random-start ovarian stimulation in patients with cancer","volume":"27","author":"Cakmak","year":"2015","journal-title":"Curr Opin Obstet Gynecol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12958-018-0367-5","article-title":"The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle","volume":"16","author":"Haas","year":"2018","journal-title":"Reprod Biol Endocrinol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3346\/jkms.2015.30.3.290","article-title":"Efficacy of random-start controlled ovarian stimulation in cancer patients","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.rbmo.2012.02.020","article-title":"The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women","volume":"24","author":"Checa","year":"2012","journal-title":"Reprod Biomed Online."},{"key":"B43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.rbmo.2013.01.003","article-title":"Response to ovarian stimulation in patients facing gonadotoxic therapy","volume":"26","author":"Johnson","year":"2013","journal-title":"Reprod Biomed Online."},{"key":"B44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/09513590.2018.1534950","article-title":"Effect of letrozole added to gonadotropins in controlled ovarian stimulation protocols on the yield and maturity of retrieved oocytes","volume":"35","author":"Ben-Haroush","year":"2019","journal-title":"Gynecol Endocrinol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","article-title":"Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment","volume":"97","author":"Domingo","year":"2012","journal-title":"Fertil Steril."},{"key":"B46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/medsci7090095","article-title":"A review of first line infertility treatments and supporting evidence in women with polycystic ovary syndrome","volume":"7","author":"Costello","year":"2019","journal-title":"Med Sci (Basel)."},{"key":"B47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/CCO.0000000000000380","article-title":"Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art","volume":"29","author":"Lambertini","year":"2017","journal-title":"Curr Opin Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.fertnstert.2012.04.021","article-title":"Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma\u2013evaluation by using antim\u00fcllerian hormone and retrieved oocytes","volume":"98","author":"Lawrenz","year":"2012","journal-title":"Fertil Steril."},{"key":"B49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10815-016-0689-1","article-title":"Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies","volume":"33","author":"Lekovich","year":"2016","journal-title":"J Assist Reprod Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2017.07.001","article-title":"Fertility and pregnancy issues in BRCA-mutated breast cancer patients","volume":"59","author":"Lambertini","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/humupd\/dmz043","article-title":"BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging","volume":"26","author":"Turan","year":"2020","journal-title":"Hum Reprod Update."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1200\/JCO.19.02399","article-title":"Pregnancy after breast cancer in patients with germline BRCA mutations","volume":"38","author":"Lambertini","year":"2020","journal-title":"J Clin Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s10815-013-0024-z","article-title":"Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation","volume":"30","author":"Barcroft","year":"2013","journal-title":"J Assist Reprod Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10815-015-0533-z","article-title":"Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment","volume":"32","author":"Dolmans","year":"2015","journal-title":"J Assist Reprod Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/humrep\/dev288","article-title":"Assisted reproductive technology use and outcomes among women with a history of cancer","volume":"31","author":"Luke","year":"2016","journal-title":"Hum Reprod."},{"key":"B57","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.rbmo.2014.09.002","article-title":"Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer","volume":"29","author":"Martinez","year":"2014","journal-title":"Reprod Biomed Online."},{"key":"B58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/AOG.0000000000001248","article-title":"Successful oocyte cryopreservation in reproductive-aged cancer survivors","volume":"127","author":"Druckenmiller","year":"2016","journal-title":"Obstet Gynecol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.fertnstert.2017.11.018","article-title":"Oocyte vitrification vs. ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study","volume":"109","author":"Diaz-Garcia","year":"2018","journal-title":"Fertil Steril."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B61","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/cncr.32546","article-title":"Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation","volume":"126","author":"Letourneau","year":"2020","journal-title":"Cancer."},{"key":"B62","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s10549-017-4654-1","article-title":"How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?","volume":"168","author":"Lambertini","year":"2018","journal-title":"Breast Cancer Res Treat."},{"key":"B63","first-page":"3134","article-title":"High progesterone levels during the luteal phase related to the use of an aromatase inhibitor in breast cancer patients","volume":"21","author":"Alviggi","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.574669\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:43:49Z","timestamp":1602045829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.574669\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":63,"alternative-id":["10.3389\/fonc.2020.574669"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.574669","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"article-number":"574669"}}